Young Adult Infusion Space Experience Satisfaction Survey

NCT05720546 | Recruiting DMC

• 1 other identifier: LCCC2228
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to compare the satisfaction of Adolescent and Young Adults (AYA) receiving treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital (NCBCH). A survey and semi-structured interviews will be administered to participants to compare the experience with the built environment, with mental health staff, and between outpatient infusion spaces at NCBCH.

Conditions

Cancer

Keywords

Adolescent; survey

Outcome Measures

Primary Outcomes (1)

• General satisfaction

  General satisfaction will be measured with participants' responses to satisfaction surveys that will be administered in specific infusion spaces. Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.

  Baseline (up to 1 month)

Secondary Outcomes (3)

• Satisfaction with the built environment

  Baseline (up to 1 month)

• Satisfaction with staff interaction

  Baseline (up to 1 month)

• Satisfaction with mental health

  Baseline (up to 1 month)

Study Arms (2)

Outpatient treatment center

Subjects received an infusion in an outpatient infusion center.

Other: Baseline Survey; Other: Semi-structured interviews; Other: Follow-up Survey

Inpatient Infusion Center

Subjects received an infusion in an inpatient infusion center.

Other: Baseline Survey; Other: Semi-structured interviews; Other: Follow-up Survey

Interventions

Baseline Survey OTHER

A survey that measures participant satisfaction will be offered to participants during infusion at baseline.

Inpatient Infusion Center; Outpatient treatment center

Semi-structured interviews OTHER

Semi-structured interviews will be conducted in the same infusion spaces.

Inpatient Infusion Center; Outpatient treatment center

Follow-up Survey OTHER

A survey that measures participant satisfaction will be offered to participants during following infusion.

Inpatient Infusion Center; Outpatient treatment center

Eligibility Criteria

• Age: 18 Years - 39 Years
• Sex: all
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

A subject with a cancer diagnosis and receiving infusion in the study site

You may qualify if:

• Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
• Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
• Age 18-39 years old at enrollment.
• Receiving treatment for a cancer diagnosis in Adult Infusion Center or the Adolescent and Young Adult Infusion Center
• English speaking.

You may not qualify if:

• Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent.
• Current incarceration.

Sponsors & Collaborators

• UNC Lineberger Comprehensive Cancer Center: lead

Study Sites (1)

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, 27514, United States

RECRUITING

Related Links

• University of North Carolina Lineberger Comprehensive Cancer Center Clinical Trials

MeSH Terms

Conditions

Neoplasms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Jacob Stein

  UNC Lineberger Comprehensive Cancer Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Daniel Kleissler

CONTACT

919-928-6231; daniel_kleissler@med.unc.edu

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 31, 2023
• First Posted: February 9, 2023
• Study Start: February 20, 2023
• Primary Completion (Estimated): August 31, 2026
• Study Completion (Estimated): August 31, 2026
• Last Updated: October 24, 2025

Record last verified: 2025-10

Locations

US (1)